180 Life Sciences Corp. (ATNF)

1.8000 +0.0700 (+4.05%) At close: 04:00PM EDT

180 Life Sciences Corp.

Building 4
Suite 200 3000 El Camino Real
Palo Alto, CA 94306
United States
650 507 0669
https://180lifesciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder & Executive Chairman	168.75k	N/A	1948
Dr. James N. Woody M.D., Ph.D.	CEO & Director	617.77k	N/A	1942
Mr. Ozan Pamir C.F.A.	CFO & Secretary	410.24k	N/A	1992
Dr. Jonathan B. Rothbard Ph.D.	Chief Scientific Officer	260.34k	N/A	1953
Prof. Jagdeep Nanchahal	Co-Founder & Chairman of Clinical Advisory Board	N/A	N/A	N/A
Mr. Jason Assad	Director of IR	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Corporate governance

180 Life Sciences Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.